2007-2008 Grant Awards Announcement
The Lytmos Group, LLC and the Florida Department of Health are pleased to announce that beginning July 1, 2007, 47 Florida scientists will receive research grants worth over $16.4 million. The scientists and their institutions were notified by the department on May 30.
The Florida Department of Health funds biomedical research through two programs, the James and Esther King Biomedical Research Program and the William G. "Bill" Bankhead, Jr. and David Coley Cancer Research Program. The King Program named for Senator King's (R-Jacksonville) parents who both died as a result of smoking, funds research into the cure, prevention, diagnosis, and treatment of tobacco-related diseases. The Bankhead-Coley Cancer program named for two legislators who recently died of cancer, funds research to find cures for cancer.
Click here for a copy of the full announcement.
About the Florida Biomedical Research Program
In 1999, the Florida Legislature established a Biomedical Research Program; now known as the James and Esther King Biomedical Research Program, to support biomedical and behavioral research for the prevention, diagnosis, treatment, and cure of tobacco-related diseases. Since its inception, Program funding has come from the interest earned on a $150 million reserve within the Lawton Chiles Endowment Fund, a fund established with monies received from the tobacco industry through Florida’s tobacco lawsuit settlement agreement (s. 215.5601, Florida Statutes (F.S.)). Additionally, beginning in fiscal year 2006-2007, the Florida legislature appropriated a sum of $6 million from recurring funds in the General Revenue Fund to the Biomedical Research Trust Fund within the Florida Department of Health for purposes of the James and Esther King Biomedical Research Program pursuant to s. 215.5602, F.S. From these funds up to $250,000 shall be available for the operating costs of the Florida Center for Universal Research to Eradicate Disease. The Florida Department of Health, through the Office of Public Health Research administers the James and Esther King Biomedical Research Program (hereafter referred to as “the Program”) with the support of a sub-contracting partner, the Lytmos Group. The Program also solicits program recommendations and suggestions on policy alternatives from the Biomedical Research Program Advisory Council consistent with Chapter 20, and s. 215.5602, F.S.